Lichtenstein Patch or Prolene Hernia System (PHS) for Inguinal Hernia Repair
Not Applicable
Completed
- Conditions
- Chronic Pain
- Registration Number
- NCT01070693
- Lead Sponsor
- Helsinki University Central Hospital
- Brief Summary
This randomised prospective study was designed to compare the convalescence and the long-term sequelae in inguinal hernia repair with either a bilayer mesh as devised by Gilbert (Prolene Hernia System®) or an onlay mesh applied according to Lichtenstein.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
- Uni- or bilateral
- Primary or recurrent
Exclusion Criteria
- body-mass index over 40kg/m2, severe co-morbidities
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Long-term Sequelae 5 years Any pain at five years
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms underlying chronic pain after inguinal hernia repair with Prolene Hernia System® or Lichtenstein Patch?
How does the Prolene Hernia System® compare to Lichtenstein Patch in long-term recurrence rates and chronic pain outcomes?
Are there specific biomarkers that predict better outcomes with bilayer mesh versus onlay mesh in inguinal hernia repair?
What adverse events are associated with Prolene Hernia System® and Lichtenstein Patch in NCT01070693 trial?
What are the current advancements in hernia mesh technology since the 2001-2009 Lichtenstein vs Prolene Hernia System® trial?
Trial Locations
- Locations (1)
Helsinki University Central Hospital
🇫🇮Espoo, Finland
Helsinki University Central Hospital🇫🇮Espoo, Finland